These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2912738)

  • 1. Sexual dimorphism of erythropoietin-degrading activity in mouse submaxillary gland extracts.
    Tam RC; Bedwell J; Cotes PM; Reed PJ
    Exp Hematol; 1989 Feb; 17(2):160-3. PubMed ID: 2912738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Damage of tracer erythropoietin results in erroneous estimation of concentration in mouse submaxillary gland.
    Vidal A; Carcagno M; Criscuolo M; Barcelò AC; Alippi RM; Leal T; Bozzini CE
    Exp Hematol; 1993 Feb; 21(2):299-302. PubMed ID: 8425566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased immunoreactive erythropoietin in serum and kidney extracts.
    Hopfer SM; Sunderman FW; Reid MC; Goldwasser E
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):299-305. PubMed ID: 6709964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.
    Egrie JC; Cotes PM; Lane J; Gaines Das RE; Tam RC
    J Immunol Methods; 1987 May; 99(2):235-41. PubMed ID: 3584994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors in the rat submaxillary gland that stimulate growth of cultured glioma cells: identification and partial characterization.
    McClure DB; Ohasa S; Sato GH
    J Cell Physiol; 1981 May; 107(2):195-207. PubMed ID: 6972945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
    Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
    Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of iodine labeled recombinant human erythropoietin.
    Kinoshita H; Ohishi N; Okazaki A
    Arzneimittelforschung; 1991 May; 41(5):568-70. PubMed ID: 1898429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual dimorphism of SDS peptide patterns from the submaxillary glands of mice.
    Kim YK; Ogita Z
    J Exp Zool; 1981 Dec; 218(3):447-53. PubMed ID: 7338729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the submandibular salivary gland on the erythropoietin response to hypoxia in mice with chronic renal failure.
    Hamilton DL; Cotes PM
    Exp Hematol; 1994 Mar; 22(3):256-60. PubMed ID: 8112424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive erythropoietin in rodent submaxillary gland. Autonomic control of exocrine secretion and factors influencing its concentration.
    Bozzini CE; Alippi RM; Barcelo AC; Elverdin JC
    Acta Odontol Latinoam; 1990; 5(1):5-12. PubMed ID: 2076164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
    Russell G; Gore CJ; Ashenden MJ; Parisotto R; Hahn AG
    Eur J Appl Physiol; 2002 Mar; 86(5):442-9. PubMed ID: 11882931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of kidney and liver in degradation of circulating submaxillary renin in mice.
    Ho SC; Izumi H; Cojocel C; Michelakis AM
    J Lab Clin Med; 1984 Jan; 103(1):125-36. PubMed ID: 6361185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
    Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of erythropoietin in genetically anemic mice.
    Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
    Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an in-house radioimmunoassay for erythropoietin.
    Fingerová H; Petrová P; Strnad M
    Acta Univ Palacki Olomuc Fac Med; 1994; 138():21-3. PubMed ID: 8714087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-degrading activity in acid-ethanol extract of rat submandibular gland.
    Tahara Y; Shima K; Hirota M; Tanaka A; Ikegami H; Yamamoto Y; Fukuda M; Kumahara Y
    Horm Metab Res; 1986 Dec; 18(12):800-3. PubMed ID: 3817745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.